ProfessorGuenther Eissner
Full Professor of Translational Systems Biology
School of Medicine
Orcid identifier0000-0002-1714-0451 (opens in a new tab)
- Full Professor of Translational Systems BiologySchool of Medicine
- 01 716 6325
- University College Dublin, School of Medicine, Systems Biology Ireland Belfield Dublin 4
BIO
2008-2013 Munich University Medical Ctr, Munich, Germany - Professor of Interdisciplinary Stem Cell Research;
2004-2007 Gentium, Sp.A., Villa Guardi (CO), Italy - S.V.P. and Head of Biological Research;
1998-2004 Regensburg University Medical Ctr, Regensburg, Germany - Head of the Lab for Experimental Stem Cell Transplantation, 2000-2002 HEISENBERG fellowship of the German Research Foundation (DFG);
1992-1998 Helmholtz Ctr Munich, Institute for Clinical Molecular Biology - Posdoctoral Fellow;
Günther Eissner graduated from the Philipps-University of Marburg, Germany with a PhD in Human Biology. After his PhD thesis in the Dept. of Immunology at the University of Munich, he was a postdoc at the Institute for Clinical Molecular Biology, Helmholtz Centre Munich, where he advanced to become a group leader working on endothelial cell biology and inflammation in the course allogeneic haematopoietic stem cell transplantation (SCT). In 1998, he moved to the University of Regensburg to head the Lab for Experimental Allogeneic Bone Marrow Transplantation. He served as Senior Vice President and Head of Biological Research of the Italian pharmaceutical company Gentium, Sp.A, Villa Guardia (CO), Italy, 2004-2007. His work on the prophylactic use of the company's lead product Defibrotide contributed to clinical studies as well as the EMA (2013) and FDA (2016) approvals and market authorisation for the treatment of veno-occlusive disease following SCT. In 2007 he was appointed to the Chair for Interdisciplinary Stem Cell Research at the University of Munich. His major research focus is on endothelial and mesenchymal stem cells in transplant medicine and oncology, i.e. the monitoring and preventing endothelial-specific adverse immunological reactions in transplant settings and the development of new tumour-specific anti-angiogenic strategies in cancer. He has given more than 50 invited lectures, and has authored /co-authored more than 70 peer-reviewed publications. UCD Medicine Research Individual Investigator
2004-2007 Gentium, Sp.A., Villa Guardi (CO), Italy - S.V.P. and Head of Biological Research;
1998-2004 Regensburg University Medical Ctr, Regensburg, Germany - Head of the Lab for Experimental Stem Cell Transplantation, 2000-2002 HEISENBERG fellowship of the German Research Foundation (DFG);
1992-1998 Helmholtz Ctr Munich, Institute for Clinical Molecular Biology - Posdoctoral Fellow;
Günther Eissner graduated from the Philipps-University of Marburg, Germany with a PhD in Human Biology. After his PhD thesis in the Dept. of Immunology at the University of Munich, he was a postdoc at the Institute for Clinical Molecular Biology, Helmholtz Centre Munich, where he advanced to become a group leader working on endothelial cell biology and inflammation in the course allogeneic haematopoietic stem cell transplantation (SCT). In 1998, he moved to the University of Regensburg to head the Lab for Experimental Allogeneic Bone Marrow Transplantation. He served as Senior Vice President and Head of Biological Research of the Italian pharmaceutical company Gentium, Sp.A, Villa Guardia (CO), Italy, 2004-2007. His work on the prophylactic use of the company's lead product Defibrotide contributed to clinical studies as well as the EMA (2013) and FDA (2016) approvals and market authorisation for the treatment of veno-occlusive disease following SCT. In 2007 he was appointed to the Chair for Interdisciplinary Stem Cell Research at the University of Munich. His major research focus is on endothelial and mesenchymal stem cells in transplant medicine and oncology, i.e. the monitoring and preventing endothelial-specific adverse immunological reactions in transplant settings and the development of new tumour-specific anti-angiogenic strategies in cancer. He has given more than 50 invited lectures, and has authored /co-authored more than 70 peer-reviewed publications. UCD Medicine Research Individual Investigator
UNIVERSITY COLLEGE DUBLIN APPOINTMENTS
- Chair of Translational Systems BiologyUniversity College Dublin, Systems Biology Ireland, Dublin, Ireland1 May 2013
ACADEMIC POSITIONS
- Professor of Interdisciplinary Stem Cell ResearchMunich University Medical Ctr, Munich, Germany, Depart of Cardiac Surgery, Munich, Germany1 Jan 2008 - 30 Apr 2013
- Head of the Lab for Experimental Stem Cell TransplantationRegensburg University Medical Ctr, Regensburg, Germany1 May 1998 - 30 Jul 2004
NON-ACADEMIC POSITIONS
- S.V.P. and Head of Biological ResearchGentium, Sp.A., Villa Guardi (CO), Italy1 Aug 2004 - 31 Dec 2007
DEGREES
- MSc, University of Marburg practial work: MPI Biochemistry Martinsried-
- PhD, Univ. of Marburg; practical work: Univ.of Munich (Dept Immunology)-
CERTIFICATIONS
- Consultant Immunologist (DGFI)German Society of Immunology, Germany
POSTGRADUATE TRAINING
- Postdoctoral FellowHelmholtz Center Munich, Institute for Clinical Molecular Biology, Germany